Tonaya Reid, Naz Reid’s sister, shot and killed on Saturday in New Jersey
Toraya Reid, the sister of Timberwolves forward Naz Reid, was shot and killed outside of a New Jersey apartment complex on Saturday morning, according to the Ocean County prosecutor’s office.
Prosecutor Bradley D. Billhimer announced Shaquille Green was charged with murder in connection with the death, which took place in Jackson Township.
According to Billhimer, officers from Jackson Township police received a 911 call reporting shots fired and an unresponsive female on the roadway outside of the apartment complex. There, officers found Toraya Reid, who was deceased.
Other officers then saw Green running down a road. Green was taken into custody and transported to police headquarters.
Billhimer said the subsequent investigation determined Green — who he said had been in a dating relationship with Reid — is allegedly the individual responsible for the death.
Naz Reid is set to enter his seventh season in Minnesota, where he’s become a fan favorite, this fall. Reid signed a five-year deal this summer to remain with the Timberwolves.
More Stories
Meta and TikTok fail to halt thousands of social media addiction lawsuits
A US appeals court has rejected a challenge by Meta and TikTok, allowing wider litigation against major platforms to proceed...
Harrods returns to £84.9m profit after Al Fayed compensation payouts
Harrods returned to a pre-tax profit of £84.9 million in the year to the end of January, according to its...
Beyoncé buys out LVMH’s stake in SirDavis whisky brand
Beyoncé has acquired full control of SirDavis, the American whisky brand she established two years ago with LVMH, after the...
87% of parents want entrepreneurial skills taught in schools
More than a third of British parents (35 per cent) would rather their child start a business than go to...
Cambridge Aerospace valued at $3.4bn after raising $300m
Defence technology company Cambridge Aerospace has raised $300 million at a valuation of $3.4 billion, two years after it was...
Rare disease investment rises after US voucher renewal, UK lags
Investment in rare disease biotechs has increased since the US Food and Drug Administration’s Rare Pediatric Disease Priority Review Voucher...
